OncoZenge AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020
Period Ending	Mar '26 Mar 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020
Market Capitalization	81	85	44	36	64	135	Upgrade
Market Cap Growth	9.45%	94.64%	21.36%	-43.82%	-52.42%	-	Upgrade
Enterprise Value	84	81	38	20	32	80	Upgrade
Last Close Price	5.74	6.76	3.75	3.09	5.50	11.56	Upgrade
PS Ratio	28.96	30.71	43924.67	12064.64	-	-	Upgrade
PB Ratio	9.51	10.09	4.42	1.94	1.90	1.69	Upgrade
P/TBV Ratio	49.56	52.55	14.17	3.07	2.38	1.84	Upgrade
EV/Sales Ratio	30.32	29.24	38094.67	6750.97	-	-	Upgrade
EV/EBITDA Ratio	-	-	-	2.79	11.43	-	Upgrade
Debt / Equity Ratio	0.89	0.89	-	-	-	-	Upgrade
Net Debt / Equity Ratio	0.45	0.45	-0.39	-0.68	-0.86	-0.64	Upgrade
Net Debt / EBITDA Ratio	-	-	-	-1.74	-10.53	-	Upgrade
Asset Turnover	0.16	0.16	0	0	-	-	Upgrade
Quick Ratio	0.74	0.74	2.95	7.81	10.22	10.62	Upgrade
Current Ratio	1.01	1.01	3.09	7.94	10.29	10.63	Upgrade
Return on Equity (ROE)	-173.01%	-173.01%	-60.77%	-60.45%	-81.62%	-7.09%	Upgrade
Return on Assets (ROA)	-55.07%	-55.07%	-34.17%	-34.73%	-20.88%	-4.95%	Upgrade
Return on Capital Employed (ROCE)	-98.80%	-98.80%	-87.30%	-85.30%	-60.10%	-6.10%	Upgrade
Earnings Yield	-19.77%	-18.64%	-19.78%	-43.94%	-72.41%	-2.87%	Upgrade
Buyback Yield / Dilution	-3.56%	-3.56%	-	-	0.53%	-	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.